Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523) [Phase 2]
Phase 2 trial results for SCH 503034 in previously untreated genotype 1 chronic hepatitis C show safety and efficacy outcomes, with the stud…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2a plus ribavirin for treating Hepatitis C in HIV-infected patients completed, with resul…
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED) [Phase 3]
A Phase 3 trial evaluating boceprevir in previously untreated patients with chronic hepatitis C genotype 1; results on safety and efficacy h…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Chiron Corp HCV E1/E2 Vaccine [Phase 1]
Phase 1 study of Chiron's Hepatitis C E1/E2 vaccine sponsored by NIAID has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus [Phase 1]
Phase 1 repeat-dose trial of bavituximab in patients co-infected with hepatitis C and HIV has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Drug-Drug Interaction Study Between Telaprevir and Buprenorphine [Phase 1]
Phase 1 drug-drug interaction study between telaprevir and buprenorphine has been completed, evaluating safety and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment [Phase 1]
This document reports an update from a Phase 1b study of Omega DUROS in patients with chronic hepatitis C who relapsed after prior treatment…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance [Phase 1]
Pfizer completed a Phase 1 drug interaction study to evaluate the interaction between filibuvir and methadone in individuals on chronic meth…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C [Phase 4]
A Phase 4 clinical trial update examining how antiviral therapy for chronic hepatitis C affects bone mineral density and metabolism.
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease
A clinical trial update evaluating the use of real-time tissue elastography to assess liver fibrosis in chronic liver disease, including chr…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: MMF Influence on HCV Viral Evolution After Liver Transplantation
A completed Mayo Clinic-sponsored clinical trial studied how mycophenolate mofetil (MMF) affects hepatitis C virus evolution in liver transp…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing [Phase 1]
A Phase 1 study evaluating safety, tolerability and pharmacokinetics of increasing oral doses of TMC435350 after single and repeated dosing …
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection [Phase 2]
Phase 2 clinical trial investigating coinfection of Hepatitis C and HIV has completed. Anemia is listed among the study conditions.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) [Phase 2]
Phase 2 study evaluating erythropoietic response in hepatitis C patients treated with ribavirin plus interferon or ribavirin plus pegylated …
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C [Phase 4]
An open-label Phase 4 study evaluated the safety and pharmacokinetics of nelfinavir in subjects with HIV infection and Hepatitis C. The tria…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects [Phase 1]
Pfizer completed a Phase 1 study of CPG10101 in relapsed hepatitis C patients, reporting safety and early signals of efficacy.
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients? [NA]
A clinical trial update examining whether vitamin D supplementation improves sustained virologic response in genotype 2 and 3 chronic hepati…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2a as maintenance therapy and its effect on liver disease progression in people co-infect…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b
A clinical trial update reports that chronic hepatitis C genotype 1a shows a better virological response to antiviral therapy than genotype …
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)
Clinical trial update reporting results on whether patient support from medical staff improves adherence to PegIntron (peginterferon alfa-2b…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol) [Phase 1]
A Phase 1 trial assessed whether steady-state filibuvir alters the pharmacokinetics of oral contraceptives levonorgestrel and ethinyl estrad…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) [Phase 3]
This document provides a Phase 3 trial update on pegylated interferon alfa-2b in patients with hepatitis C-related cirrhosis and high liver …
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Australian Trial in Acute Hepatitis C [Phase 4]
An update on a Phase 4 Australian clinical trial for acute Hepatitis C, which has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-30Clinical Trial Update: Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients [Phase 2]
Phase 2 trial assessing efficacy and safety of escitalopram for preventing depression induced by peg-interferon in Hepatitis C patients; stu…
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED) [Phase 4]
Phase 4 trial comparing non-extended versus 24-week extended Peg-Intron (pegylated interferon alfa-2b) with ribavirin in genotype 1 chronic …